Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Monthly Communication Reports in: December 2021

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

The list below is sorted by communication date, beginning with the most recent.

Innovative Medicines Canada/Médicaments novateurs Canada

Pamela Fralick, President (Organization)

Results 1-8 of 8

  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Holly Duggan, Director of Outreach and Stakeholder Relations | House of Commons
    • Alex MacDonald, Policy Advisor, Health, Office of the Leader of the Opposition | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-12-15
    Posted date: 2022-01-13
    Communication number: 371-519439 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy , Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry
    Communication date: 2021-12-10
    Posted date: 2022-01-13
    Communication number: 371-519429 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Leslyn Lewis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-12-09
    Posted date: 2022-01-13
    Communication number: 371-519438 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)
    • Eric Belair , Associate Assistant Deputy Minister | Health Canada (HC)
    • Nancy Hamzawi, Federal Lead and Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-12-03
    Posted date: 2022-01-13
    Communication number: 371-519426 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean-Yves Duclos , Minister of Health | Health Canada (HC)
    • Jean-Sébastien Bock, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-12-02
    Posted date: 2022-01-13
    Communication number: 371-519419 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Steven Outhouse , Deputy Chief of Staff, Office of the Leader of the Official Opposition | House of Commons

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2021-12-02
    Posted date: 2022-01-13
    Communication number: 371-519440 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Elliott Lockington , Chief of Staff | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-12-02
    Posted date: 2022-01-13
    Communication number: 371-519437 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean-Sébastien Bock , Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2021-12-01
    Posted date: 2022-01-13
    Communication number: 371-519434 View associated registration

Return to Monthly Communication Reports by Reporting Period

Date Modified: